Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Mise à jour : Il y a 4 ans
Référence : NCT00101985

Femme et Homme

Extrait

This study will evaluate the effectiveness and safety of the investigational drug talnetant in treating subjects with irritable bowel syndrome (IBS).


Critère d'inclusion

  • irritable colon


Liens